Merck to buy Schering-Plough in $41 billion deal Reported by David Jolly Publ With the purchase, Merck is expanding its franchise in cardiovascular, respiratory and oncology drugs and shoring up its research pipeline, in particular with a Schering-Plough product called TRA, a … [Read more...] about Merck Puts Some of Their Gardasil Cash To Work
arthritis
Social Networking Sites Have Myriad Trial-Related Uses
The information in this post was gathered from an article published by Deb Bortifz in eCliniqua, Innovative Management in Clinical Trials. eCliniqua offers PodCasts, WebCasts, White Papers and much more. Their 'data-rich' site is one of my primary research resources for an … [Read more...] about Social Networking Sites Have Myriad Trial-Related Uses
FDA Unveils List of 20 Drugs In Side-Effect Probes
Goal Is to Provide Signs of Possibility Of Adverse Effect By JARED A. FAVOLE Wall Street Journal WASHINGTON The Food and Drug Administration on Friday unveiled a report listing 20 drugs that the agency is investigating for potential side effects, as part of a new policy … [Read more...] about FDA Unveils List of 20 Drugs In Side-Effect Probes